Skip to content
10-Q

Quarterly Report

Luckwel Pharmaceuticals Inc.

0001493152-21-022056

← back to feed
Filed
Sep 7, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Jul 20, 2021 147.16M sh
Operating Cash Flow Q1 2021 · Jun 30, 2020 −$11.98K
Operating Cash Flow Q1 2021 · Jun 30, 2019 −$108.03K
Cash And Equivalents Q1 2021 · Jun 30, 2020 $3.06K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $44
Stockholders Equity Q1 2021 · Jun 30, 2020 −$1.4M
Stockholders Equity Q1 2021 · Mar 31, 2020 −$1.33M
Stockholders Equity Q1 2021 · Jun 30, 2019 −$932.34K
Stockholders Equity Q1 2021 · Mar 31, 2019 −$791.82K
Total Liabilities Q1 2021 · Jun 30, 2020 $1.42M
Total Liabilities Q1 2021 · Mar 31, 2020 $1.35M
Total Assets Q1 2021 · Jun 30, 2020 $13.41K
Total Assets Q1 2021 · Mar 31, 2020 $17.21K
Sga Expense Q1 2021 · Jun 30, 2020 $74.48K
Sga Expense Q1 2021 · Jun 30, 2019 $140.52K
Net Income Q1 2021 · Jun 30, 2020 −$74.7K
Net Income Q1 2021 · Jun 30, 2019 −$140.51K